- Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression2019 | First Faculty of Medicine
- IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA12007 | First Faculty of Medicine
- Patients with IgA nephropthy have increased serum galactose-deficient IgA1 levels2007 | First Faculty of Medicine
- Galactose deficient IgA1 - containing circulatinh immune complexes from IgA nepropathy patientsPublication without faculty affiliation
- IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA12007 | Faculty of Physical Education and Sport
- Patients with IgA nephropthy have increased serum galactose-deficient IgA1 levels2007 | Faculty of Physical Education and Sport
- Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schonlein purpura2007 | First Faculty of Medicine
- Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schonlein purpura2007 | Faculty of Physical Education and Sport
- Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity2009 | First Faculty of Medicine
- Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies1999 | Second Faculty of Medicine
- Recognition of Galactose-Deficient O-Glycans in the Hinge Region of IgA1 by N-Acetylgalactosamine-Specific Snail Lectins: A Comparative Binding Study2010 | First Faculty of Medicine
- Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors2022 | Second Faculty of Medicine
- New Treatment Strategies for IgA Nephropathy: Targeting Plasma Cells as the Main Source of Pathogenic Antibodies2022 | First Faculty of Medicine
- Glucocorticoids Reduce Aberrant O-Glycosylation of IgA1 in IgA Nephropathy Patients2018 | First Faculty of Medicine, Second Faculty of Medicine
- Toward Noninvasive Diagnosis of IgA Nephropathy: A Pilot Urinary Metabolomic and Proteomic Study2016 | First Faculty of Medicine
- IgA Nephropathy: Molecular Mechanisms of the Disease2013 | First Faculty of Medicine, Second Faculty of Medicine
- Role of Epstein-Barr Virus in Pathogenesis and Racial Distribution of IgA Nephropathy2020 | Second Faculty of Medicine
- IgA Nephropathy and Related Diseases2015 | First Faculty of Medicine
- IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells2005 | Second Faculty of Medicine
- Markers for the progression of IgA nephropathy2016 | First Faculty of Medicine
- Expanding options of supportive care in IgA nephropathy2023 | First Faculty of Medicine
- Emerging role of monoclonal antibodies in the treatment of IgA nephropathy2023 | First Faculty of Medicine
- IgA Nephropathy: A Clinical Overview2007 | Second Faculty of Medicine
- IgA Nephropathy. Facts, uncertainties, and potential causal therapy approaches2015 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport